Purpose: We investigate the efficacy of sacral neurostimulation in patients
with idiopathic urinary retention in a prospective, randomized multicenter
trial.
Materials and Methods: A total of 177 patients with urinary retention refra
ctory to standard therapy were enrolled in the study. Greater than 50% impr
ovement in baseline voiding symptoms during a 3 to 7-day percutaneous test
stimulation qualified a patient for surgical implantation of an InterStim p
arallel to system. Of the patients who qualified for implantation 37 were r
andomly assigned to a treatment and 31 to a control group. Patients in the
treatment group underwent early surgical implantation of the sacral nerve s
timulation system, while implantation was delayed in the control group for
6 months. Followup evaluations, including voiding diary analysis and tempor
ary deactivation of the stimulator at 6 months, were conducted at 1, 3, 6,
12 and 18 months after implantation in the treatment group, and after 3 and
6 months in the control group.
Results: Compared to the control group, patients implanted with the InterSt
im system had statistically and clinically significant reductions in the ca
theter volume per catheterization (p <0.0001). Of the patients treated with
implants 69% eliminated catheterization at 6 months and an additional 14%
had a 50% or greater reduction in catheter volume per catheterization. Ther
efore, successful results were achieved in 83% of the implant group with re
tention compared to 9% of the control group at 6 months. Temporary inactiva
tion of sacral nerve stimulation therapy resulted in a significant increase
in residual volumes (p <0.0001) but effectiveness of sacral nerve stimulat
ion was sustained through 18 months after implant.
Conclusions: Results of this prospective, randomized clinical study demonst
rate that sacral nerve stimulation is effective for restoring voiding in pa
tients with retention who are refractory to other forms of treatment.